Suppr超能文献

氯美噻唑对大鼠脑内GABAA受体复合物的调节作用

The modulation by chlormethiazole of the GABAA-receptor complex in rat brain.

作者信息

Cross A J, Stirling J M, Robinson T N, Bowen D M, Francis P T, Green A R

机构信息

Astra Neuroscience Research Unit, Institute of Neurology, London.

出版信息

Br J Pharmacol. 1989 Sep;98(1):284-90. doi: 10.1111/j.1476-5381.1989.tb16893.x.

Abstract
  1. The interactions of chlormethiazole with gamma-aminobutyric acid (GABA) synthesis and release, and with ligand binding to sites associated with the GABAA-receptor complex and the GABAB-receptor have been studied in the rat. The GABAA-receptor was studied using [3H]-muscimol, [3H]-flunitrazepam was used to label the benzodiazepine modulatory site, and [35S]-butyl-bicyclophosphorothionate ([35S]-TBPS) to label the chloride channel. 2. Chlormethiazole had no effect on GABA synthesis in the cortex, hippocampus and striatum or on GABA release from cortical slices in vitro. Chlormethiazole did not displace [3H]-baclofen binding to the GABAB-receptor. 3. Chlormethiazole (IC50 = 140 microM) and pentobarbitone (IC50 = 95 microM) both inhibited [35S]-TBPS binding by increasing the rate of [35S]-TBPS dissociation. In addition, chlormethiazole caused an apparent decrease in the affinity of [35S]-TBPS binding. 4. Chlormethiazole enhanced the binding of [3H]-muscimol but had no effect on [3H]-flunitrazepam binding. In contrast, the sedative barbiturate pentobarbitone enhanced both [3H]-muscimol and [3H]-flunitrazepam binding. 5. It is concluded that the sedative and anticonvulsant effects of chlormethiazole are probably mediated through an action at the GABAA-receptor. However, chlormethiazole does not interact with the GABAA-receptor complex in an identical manner to the sedative barbiturate pentobarbitone.
摘要
  1. 已在大鼠中研究了氯美噻唑与γ-氨基丁酸(GABA)合成及释放的相互作用,以及与GABAA受体复合物和GABAB受体相关位点的配体结合情况。使用[3H]-蝇蕈醇研究GABAA受体,用[3H]-氟硝西泮标记苯二氮䓬调节位点,用[35S]-丁基双环磷硫代酸盐([35S]-TBPS)标记氯离子通道。2. 氯美噻唑对皮质、海马体和纹状体中的GABA合成或体外皮质切片中的GABA释放均无影响。氯美噻唑不取代[3H]-巴氯芬与GABAB受体的结合。3. 氯美噻唑(IC50 = 140微摩尔)和戊巴比妥(IC50 = 95微摩尔)均通过增加[35S]-TBPS解离速率来抑制[35S]-TBPS结合。此外,氯美噻唑使[35S]-TBPS结合的亲和力明显降低。4. 氯美噻唑增强了[3H]-蝇蕈醇结合,但对[3H]-氟硝西泮结合无影响。相比之下,镇静性巴比妥类药物戊巴比妥增强了[3H]-蝇蕈醇和[3H]-氟硝西泮的结合。5. 得出结论,氯美噻唑的镇静和抗惊厥作用可能是通过作用于GABAA受体介导的。然而,氯美噻唑与GABAA受体复合物的相互作用方式与镇静性巴比妥类药物戊巴比妥不同。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验